Cincera Therapeutics is a privately held biotechnology company based in Melbourne, Australia. The company is focused on the discovery and development of new drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity/metabolic diseases, with potential applications in many other disease areas including cancer. The company will initially focus on treatments for the emerging epidemic of a liver disease termed ‘NASH’ (non-alcoholic steatohepatitis).
The Cincera team has developed novel drug like lead compounds that specifically inhibit a key enzymatic target in a lipid metabolism pathway. The novel and differentiated approach of Cincera is derived from the innovative research of its academic co-founders: medicinal chemist and entrepreneur Associate Professor Bernard Flynn, from the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University (Monash) in Melbourne, and lipid biologist Professor Stuart Pitson, from the Centre for Cancer Biology (CCB) at the University of South Australia (UniSA) in Adelaide.
The company is funded by the Medical Research Commercialisation Fund (MRCF), which is managed by the life science specialist venture capital management firm – Brandon Capital Partners (BCP).
Company Details
- Employees
- 3
- Founded
- -
- Address
- 31 Queen Street, Level 9,australia
- in****@****atx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cinceratx.com
- Keywords
- biotechnology.
- HQ
- Melbourne, VIC
Cincera Therapeutics Pty Ltd Questions
Cincera Therapeutics Pty Ltd's website is cinceratx.com
Cincera Therapeutics Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/cincera-therapeutics-pty-ltd
Cincera Therapeutics Pty Ltd has
3 employees.
View email and phone details for 3
employees at Cincera Therapeutics Pty Ltd.
Cincera Therapeutics Pty Ltd's industry is
Biotechnology Research
Cincera Therapeutics Pty Ltd's top competitors are
Invex Therapeutics,
Kiora Pharmaceuticals, Inc.,
Rage Biotech,
Kinoxis Therapeutics Pty Ltd,
Denteric Pty Ltd,
Occurx,
Currus Biologics Pty Ltd,
Aravax,
Inosi Therapeutics Pty Ltd,
Certa Therapeutics.
Cincera Therapeutics Pty Ltd's support email address is info@cinceratx.com
Cincera Therapeutics Pty Ltd's categories are Biotechnology Research
Cincera Therapeutics Pty Ltd's founding year is 2018
